{"id":680879,"date":"2023-12-12T18:20:01","date_gmt":"2023-12-12T18:20:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=680879"},"modified":"2023-12-12T18:20:01","modified_gmt":"2023-12-12T18:20:01","slug":"diagnostic-imaging-market-worth-346-billion-by-2028","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/diagnostic-imaging-market-worth-346-billion-by-2028_680879.html","title":{"rendered":"Diagnostic Imaging Market worth $34.6 billion by 2028"},"content":{"rendered":"
\n
\"Diagnostic<\/a><\/div>\n
\n
Siemens is a leading player in the diagnostic imaging market due to its robust imaging product portfolio, including MRI, Ultrasound, X-ray systems, and nuclear imaging equipment. The company has major R&D facilities in Germany, the US, China, and India. The company offers a wide range of products and services in point-of-care diagnostics, laboratory testing, diagnostics and therapeutic screening, and molecular medicine.<\/div>\n<\/div>\n<\/div>\n
The global diagnostic imaging services market size is projected to reach USD 702.6 billion by 2027, at a CAGR of 5.1%.<\/div>\n

Diagnostic Imaging Market<\/a><\/strong> in terms of revenue was estimated to be worth $26.5 billion in 2023 and is poised to reach $34.6 billion by 2028, growing at a CAGR of 5.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The major factors driving the growth of this market include the launch of technologically advanced products by the key players and increasing prevalence of chronic diseases.<\/p>\n

Download an Illustrative overview: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=411<\/a><\/strong><\/p>\n

Mammography systems segment to register significant growth rate over the forecast period of 2023-2028.<\/strong><\/p>\n

Based on the product, the global diagnostic imaging market is segmented into CT scanners, X-ray imaging systems, ultrasound systems, MRI systems, nuclear imaging systems, and mammography systems. The mammography systems segment is anticipated to register the highest growth rate over the forecast period. The CT scanners segment accounted for the highest share of the diagnostic imaging market in 2022.<\/p>\n

Cardiology application segment accounted for the largest share of the CT scanners market, by application in 2022.<\/strong><\/p>\n

Based on application, the diagnostic imaging market is segmented into MRI systems – brain and neurological MRI, spine and musculoskeletal MRI, pelvic and abdominal MRI, vascular MRI, breast MRI, cardiac MRI, ultrasound systems – radiology\/general imaging, cardiology, obstetrics\/gynecology, vascular applications, urology, other applications, X-ray imaging systems – general radiography, fluoroscopy, dentistry, CT scanners- cardiology, oncology, neurology, and other applications, nuclear imaging systems – cardiology, oncology, neurology, and other applications, and mammography systems. Cardiology application segment accounted for the largest share of the market in 2022 and is also expected to grow at the highest CAGR during the forecast period.<\/p>\n

Factors such as the introduction of novel software and rising adoption of high-end instruments in end user facilities drive the growth of the market.<\/p>\n

The hospitals segment accounted for the largest share of the diagnostic imaging market, by end user, in 2022<\/strong><\/p>\n

Based on end user, the global diagnostic imaging market is segmented into hospitals, diagnostic imaging centers, and other end users. The hospitals segment accounted for the largest share of the market in 2022. Significant rise in the number of hospitals and rising old-age population are driving the growth of this segment.<\/p>\n

The Asia Pacific market to register the highest growth in the market during the forecast period<\/strong><\/p>\n

The Asia Pacific diagnostic imaging market is anticipated to register the highest growth from 2023 to 2028. Major players in the market are focusing on expanding their manufacturing capabilities in the APAC. This region is consistently witnessing a rise in the adoption of high-end equipment. Improvements in healthcare systems and government initiatives for modernizing the healthcare infrastructure are offering significant growth opportunities for the key players.<\/p>\n

Request Sample Pages: https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=411<\/a><\/strong><\/p>\n

Diagnostic Imaging Market Dynamics:<\/strong><\/p>\n

Drivers:<\/strong><\/p>\n

    \n
  1. Growing geriatric population and subsequent rise in chronic diseases<\/li>\n<\/ol>\n

    Restraints:<\/strong><\/p>\n

      \n
    1. High cost of diagnostic imaging systems<\/li>\n<\/ol>\n

      Opportunities:<\/strong><\/p>\n

        \n
      1.  Growth opportunities in emerging countries<\/li>\n<\/ol>\n

        Challenge:<\/strong><\/p>\n

          \n
        1. Shortage of trained professionals<\/li>\n<\/ol>\n

          Key Market Players:<\/strong><\/p>\n

          As of 2022, prominent players in the diagnostic imaging market are Siemens Healthineers (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan) among others.<\/p>\n

          Get 10% Free Customization on this Report: https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=411<\/a><\/strong><\/p>\n

          Media Contact<\/span>
          Company Name:<\/strong>           MarketsandMarkets\u2122 Research Private Ltd.<\/a>
          Contact Person:<\/strong> Mr. Aashish Mehra
          Email:<\/strong>           Send Email<\/a>
          Phone:<\/strong> 18886006441
          Address:<\/strong>630 Dundee Road Suite 430
          City:<\/strong> Northbrook
          State:<\/strong> IL 60062
          Country:<\/strong> United States
          Website:<\/strong>           https:\/\/www.marketsandmarkets.com\/Market-Reports\/diagnostic-imaging-market-411.html<\/a><\/p>\n

          <\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

          Siemens is a leading player in the diagnostic imaging market due to its robust imaging product portfolio, including MRI, Ultrasound, X-ray systems, and nuclear imaging equipment. The company has major R&D facilities in Germany, the US, China, and India. The … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-680879","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/680879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=680879"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/680879\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=680879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=680879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=680879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}